Hyperinsulinemia in metabolic syndrome is considered to stimulate cancer cell proliferation through the p21 Ras/mitogen‐activated protein kinase and phosphatidylinositol‐3 kinase/Akt pathways through the IGF‐1 receptor, which is overexpressed in colon cancer.30 This evidence concerns the gene AKT1 and hyperinsulinism.